Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire
HOUSTON, May 28, 2026 /PRNewswire/ -- Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ) has announced that its gene synthesis and cell-free protein expression workflow was used in a recent study by Tencent AI for Life Sciences Lab published in Nature Communications,
Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire

Small biotech firms quicker to 'latch onto' AI than big ones, says Tencent Healthcare President

SynuSight-Shanghai Jiao Tong University Collaboration Published in Cell, Advancing Diagnostic Classification of Synucleinopathies

Biocytogen lancia la piattaforma basata sull'IA RenSuper™ e la prima infrastruttura per la scoperta di anticorpi totalmente automatizzata del settore

Tutte le Big Pharma che investono nell'IA - Startmag

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

L'accordo con Innovent Biologics fa tenere a Pfizer un piede negli Usa e l'altro in Cina - Startmag

China-led initiative unveils Asia's first 10-year roadmap for synthetic cell research

Meet Clicklinks: The Innovation Hub for Original Drug Discovery

Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward

Daily briefing: The known protein universe just got a lot bigger

HONG KONG, May 28 : Small biotech firms "latch onto" AI more quickly than bigger firms, the head of Chinese tech giant Tencent's…

A deal between Shenzhen-based XTalPi and US firm DoveTree shows Chinese biotech AI capabilities are gaining recognition.

SynuSight-Shanghai Jiao Tong University Collaboration Published in Cell, Advancing Diagnostic Classification of Synucleinopathies

/C O R R E C T I O N -- Innovent Biologics/

Our podcast on science and technology. Scientists can design and make novel proteins. One day they may even be able to build…

After years of buying licences for foreign-made medicines, Chinese biotech firms are now profiting handsomely from their own…